Effects of raloxifene hydrochloride on bone mineral density, bone metabolism and serum lipids in Chi

来源 :中华医学杂志(英文版) | 被引量 : 0次 | 上传用户:netuu
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
Background Raloxifene has been approved for prevention and treatment of postmenopausal osteoporosis in Caucasian women. It also has some positive effects on serum lipids in Caucasians. The objective of this study was to determine the effect of raloxifene hydrochloride on lumbar spine and total hip bone mineral density (BMD), bone metabolism, and serum lipids in Chinese postmenopausal women with osteoporosis.Methods This was a multi-center, randomized, double-blind, placebo-controlled clinical trial in which 204 postmenopausal Chinese women with osteoporosis were assigned to receive raloxifene (60 mg) or placebo treatment daily for 12 months. BMD, serum bone metabolism markers, and serum lipids were measured before and after drug administration. BMD was measured by Dual-Energy X-Ray Absorptiometry (DEXA) and bone metabolism markers were analyzed by one-step enzyme-linked immunosorbent assay. Serum lipids were measured by enzymatic analysis.Results At the end of the 12-month study, lumbar spine BMD increased in both groups with a mean increase of (3.3±4.8) % in the raloxifene group and (1.0±4.9) % in the placebo group (P<0.001). There was a mean increase in total hip BMD of (1.4±4.8) % in the raloxifene group and a mean decrease of (0.9±5.0) % in the placebo group (P<0.001). No subject in the raloxifene group had a new vertebral fracture and 5 placebo subjects had new fractures (P>0.05). In the raloxifene group, the median decreases in the biochemical markers of bone metabolism serum osteocalcin and C-telopeptide were 41.7% and 61.5%, respectively. These changes were statistically significant compared with those in the placebo group (10.6% and 35.6%, P<0.001, respectively). Both total cholesterol and low-density lipoprotein cholesterol decreased significantly in the raloxifene group compared with those in the placebo group (P<0.001, respectively) and there was no significant effect of raloxifene on high-density lipoprotein cholesterol and triglycerides compared with placebo. Conclusions Raloxifene 60 mg/d for 12 months significantly increases lumbar spine and total hip BMD, significantly decreases bone tover, and has favourable effects on serum lipids in Chinese postmenopausal women with osteoporosis.rn
其他文献
激光对光学薄膜的损伤仍然是限制高能激光系统的主要挑战。对杂质诱导薄膜损伤的激励进行了研究:首先对损伤形貌进行了观测,在此基础上对杂质对薄膜的作用效应进行了分析。研
介绍了微测辐射热计的 12 8× 12 8凝视型非致冷红外热像仪的系统框图 ,论述了一种新型的红外焦平面阵列温控电路设计方案以及读出电路时序的FPGA实现方法 .该方案具有高集成
期刊
本科2006-2007年行中老年人下眼袋美容整形术66例,经配合医生治疗及指导护理,效果满意。现将护理体会报告如下。
大口径轻量化Si C主镜是一种新型主镜,之前没有成功的支撑案例作为参考。通过对各类大口径主镜的主动支撑技术的优劣进行分析,确定利用液压并联力促动器的支撑方式对Si C轻量化主镜进行支撑,并利用自由谐振模式定标方法研究了某4 m Si C主镜的校正力需求,计算发现该主镜对力促动器的校正力分辨率要求为0.1 N。针对这一需求,详细分析了影响机械式力促动器精度的主要因素,并进行了相应的设计,采用步进电机
由于高的电子迁移率和二维电子气浓度,InP基赝配高电子迁移率晶体管(PHEMTs)器件成为制作太赫兹器件最有前途的三端器件之一。为提高器件的工作频率,采用InAs复合沟道,使得二维
目的总结88例桡动脉路径行冠状动脉介入治疗(PCI)的护理体会。方法做好术前护理、术中配合、术后护理及心理护理和健康宣教,进行手部的观察和护理。结果所有病例均顺利完成介入
2010年上半年维达国际控股有限公司实现营业额16.82亿港元(2009年上半年为13.46亿港元),较去年同期增加25.0%;权益持有人应占溢利1.98亿港元(2009年上半年为1.8亿港元),较去